StockNews.com Initiates Coverage on Edap Tms (NASDAQ:EDAP)

Research analysts at StockNews.com assumed coverage on shares of Edap Tms (NASDAQ:EDAP) in a research report issued on Sunday. The firm set a “hold” rating on the medical equipment provider’s stock.

Edap Tms Stock Performance

Edap Tms stock opened at $2.86 on Friday. The firm has a market capitalization of $106.11 million, a P/E ratio of -4.40 and a beta of 0.36. The stock has a fifty day moving average price of $2.30 and a 200 day moving average price of $2.82. Edap Tms has a 52 week low of $2.00 and a 52 week high of $8.50. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08.

Institutional Investors Weigh In On Edap Tms

Large investors have recently modified their holdings of the stock. Illumine Investment Management LLC acquired a new stake in shares of Edap Tms in the fourth quarter valued at about $50,000. BNP Paribas Financial Markets grew its stake in shares of Edap Tms by 23.7% in the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock valued at $59,000 after buying an additional 4,400 shares in the last quarter. Jane Street Group LLC grew its stake in shares of Edap Tms by 174.7% in the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock valued at $69,000 after buying an additional 73,361 shares in the last quarter. Orion Capital Management LLC grew its stake in shares of Edap Tms by 10.4% in the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock valued at $178,000 after buying an additional 6,600 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC grew its stake in Edap Tms by 48.5% during the 4th quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock valued at $355,000 after purchasing an additional 52,500 shares in the last quarter. Institutional investors and hedge funds own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.